pharmacie et médicaments – Thérapies ciblées pour les patients touchés par un cancer bronchique

This written question concerns the availability and accessibility of targeted therapies for patients diagnosed with lung cancer. It seeks information on current policies and future strategies to ensure these advanced treatments reach those who need them. The question is directed towards government officials, aiming to understand the impact on patients, healthcare providers, and the pharmaceutical industry within France.